IRWD
Ironwood Pharmaceuticals Inc
NASDAQ: IRWD · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$4.15
-1.19% today
Updated 2026-04-29
Market cap
$658.76M
P/E ratio
26.93
P/S ratio
2.22x
EPS (TTM)
$0.15
Dividend yield
—
52W range
$1 – $6
Volume
2.8M
Ironwood Pharmaceuticals Inc (IRWD) Financial statements
SEC filings — annual and quarterly data.
Profit margin
8.11%
Operating margin
13.70%
ROE
-575.00%
ROA
19.90%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $3.14M | $-37.18M | — | -1,260.99% | -1,184.08% |
| 2007 | $10.46M | $-52.75M | 100.00% | -550.60% | -504.13% |
| 2008 | $22.22M | $-53.87M | 100.00% | -251.71% | -242.50% |
| 2009 | $36.10M | $-71.19M | 100.00% | -201.57% | -197.18% |
| 2010 | $43.86M | $-52.98M | 100.00% | -138.55% | -120.80% |
| 2011 | $65.87M | $-64.85M | 100.00% | -100.41% | -98.45% |
| 2012 | $150.25M | $-72.62M | 99.36% | -48.43% | -48.34% |
| 2013 | $22.88M | $-272.81M | 68.52% | -1,101.36% | -1,192.31% |
| 2014 | $76.44M | $-189.62M | 66.53% | -221.58% | -248.07% |
| 2015 | $149.56M | $-142.67M | 99.99% | -68.26% | -95.40% |
| 2016 | $273.96M | $-81.71M | 99.32% | -18.93% | -29.83% |
| 2017 | $298.28M | $-116.94M | 93.49% | -25.94% | -39.20% |
| 2018 | $346.64M | $-282.37M | 90.55% | -68.92% | -81.46% |
| 2019 | $428.41M | $21.50M | 68.40% | 28.04% | 5.02% |
| 2020 | $389.52M | $106.18M | 99.19% | 36.70% | 27.26% |
| 2021 | $413.75M | $528.45M | 82.98% | 56.13% | 127.72% |
| 2022 | $410.60M | $175.06M | 99.65% | 60.97% | 42.64% |
| 2023 | $442.74M | $-1.00B | 98.61% | -213.54% | -226.37% |
| 2024 | $351.41M | $880000.00 | 97.85% | 26.50% | 0.25% |
| 2025 | $296.15M | $24.02M | 99.36% | 40.10% | 8.11% |